BioSpark

BioSpark is biotech/healthcare-focused Non-Profit Organization registered in the Massachusetts. Our events calendar:

[BioSpark @BioSpark_Group]

📢We are live now!

Oct 2026 Biotech News Review https://t.co/RnKN8QHoBT via @YouTube

[BioSpark @BioSpark_Group]

Join us on Saturday, November 7th, 2026, 8:00 PM EST for a live online webinar where we unpack the most exciting biotech breakthroughs from the past month! Register Here:
https://t.co/yBQPm4gZbh

[BioSpark @BioSpark_Group]

October 2026 Biotech News Review
Join us on Saturday, November 7th, 2026, 8:00 PM EST for a live online webinar where we unpack the most exciting biotech breakthroughs from the past month!
Register Here: https://t.co/yBQPm4hx0P

[BioSpark @BioSpark_Group]

Join us on Saturday, October 3rd, 2026, 9:00 PM EST for a live online webinar where we unpack the most exciting biotech breakthroughs from the past month!
Register Here: https://t.co/mk15LiHLqT

[BioSpark @BioSpark_Group]

FDA Approves J&J's Imaavy for wAIHA: First-Ever Therapy & What It Means ... https://t.co/akmrcxdlFj via @YouTube

[BioSpark @BioSpark_Group]

Join us on Saturday, October 3rd, 2026, 9:00 PM EST for a live online webinar where we unpack the most exciting biotech breakthroughs from the past month!
Register here: https://t.co/mk15LiIjgr

[BioSpark @BioSpark_Group]

Highlights: BioSpark 2026 Annual Conference at MIT | Biotech 2026: Infle... https://t.co/mNGxt9cCqb via @YouTube

[BioSpark @BioSpark_Group]

Monthly News Yearly Review: Immunology & Biotech Business | BioSpark 2026 Annual Conference
Join us at the BioSpark Annual Conference on September 26th for a yearly review of two fields, Immunology and Biotech Business, presented by our BioSpark Monthly News speakers.

[BioSpark @BioSpark_Group]

𝗥𝗮𝗿𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲: 𝗳𝗿𝗼𝗺 𝗣𝗼𝘀𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 𝘁𝗼 𝗜𝗺𝗽𝗮𝗰𝘁𝘀: 𝗪𝗵𝗮𝘁 𝗪𝗶𝗹𝗹 𝗶𝘁 𝗧𝗮𝗸𝗲 𝘁𝗼 𝗧𝘂𝗿𝗻 𝗕𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗶𝗻𝘁𝗼 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝘁𝗵𝗮𝘁 𝗖𝗵𝗮𝗻𝗴𝗲 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀’ 𝗟𝗶𝘃𝗲𝘀?

[BioSpark @BioSpark_Group]

𝗨𝘀𝗵𝗲𝗿𝗶𝗻𝗴 𝗶𝗻 𝗮 𝗡𝗲𝘄 𝗘𝗿𝗮 𝗼𝗳 𝗥𝗡𝗔 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗳𝗼𝗿 𝗖𝗡𝗦 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 | 𝗕𝗶𝗼𝗦𝗽𝗮𝗿𝗸 𝟮𝟬𝟮𝟲 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲
📅 September 26, 2026, 9:50 AM - 10:45 AM (EDT)
📍 MIT Stata Center, Cambridge, MA
👉 Register: https://t.co/FCLaNQR4fK

[BioSpark @BioSpark_Group]

Merck & Moderna's Cancer Vaccine: Inside the First Positive Phase 3 Tria... https://t.co/6uYoVrPSCd via @YouTube

[BioSpark @BioSpark_Group]

𝗙𝗿𝗼𝗺 𝗧𝗼𝗼𝗹 𝘁𝗼 𝗣𝗼𝘄𝗲𝗿𝗵𝗼𝘂𝘀𝗲: 𝗔𝗜’𝘀 𝗡𝗲𝘅𝘁 𝗘𝗿𝗮 𝗶𝗻 𝗗𝗿𝘂𝗴 𝗥&𝗗 | 𝗕𝗶𝗼𝗦𝗽𝗮𝗿𝗸 𝟮𝟬𝟮𝟲 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲
📅 September 26, 2026, 11:15 AM-12:00 PM (EDT)
📍 MIT Stata Center, Cambridge, MA
👉 Register: https://t.co/jgr0VczYV0

[BioSpark @BioSpark_Group]

We're honored to welcome Adrian Krainer, PhD as a keynote speaker, presenting: "Antisense Modulation of mRNA Splicing for Neurological Disorders".
📅 September 26, 2026，9:00 AM (EDT)　
📍 MIT Stata Center, Cambridge, MA
👉 Register: https://t.co/jgr0VczYV0

[BioSpark @BioSpark_Group]

Investing in a New Biotech Era: Triangulating with Investors and Founders | BioSpark 2026 Annual Conference.
📅 September 26, 2026, 4:25PM-5:25PM (EDT)　
📍 MIT Stata Center, Cambridge, MA
👉 Register: https://t.co/jgr0VczYV0

[BioSpark @BioSpark_Group]

Keynote Spotlight | BioSpark 2026 Annual Conference We're honored to welcome Joseph C. Wu, MD, PhD as a keynote speaker, presenting: "New Approach Methodologies: Genomics, Stem Cells, and AI for Drug Discovery"
Register: https://t.co/jgr0VczYV0

[BioSpark @BioSpark_Group]

https://t.co/c40QKSh4HX via @YouTube
Join us on Saturday, August 29th, 2026, 9:00 PM EST for a live online webinar where we unpack the most exciting biotech breakthroughs from the past month!

[BioSpark @BioSpark_Group]

Why Abivax Crashed 30% Then Rebounded: Obefazimod's Phase 3 UC Data Expl... https://t.co/yVBHGdI10k via @YouTube

[BioSpark @BioSpark_Group]

The inflection point is here. Join us at the BioSpark 2026 Annual Conference — a full day of keynotes and panels on where biotech goes next.
📅 September 26, 2026　📍 MIT, Cambridge, MA
👉 Swipe to meet the speakers, and register at https://t.co/sreAvDlA0q

[BioSpark @BioSpark_Group]

Atacicept Approved for IgA Nephropathy: Inside Vera Therapeutics' TACI-F... https://t.co/Ydh2JOeWeO via @YouTube

[BioSpark @BioSpark_Group]

A Pill That Rivals the Injectables: Inside the First Oral PCSK9 Inhibito... https://t.co/KkM1ywaTJm via @YouTube